NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

GRANULES INDIA

BSE: 532482 22 Feb 2025
Healthcare
₹ 509.0
Granules India Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GRANULES INDIA - Share Price & Details

Market Cap
₹12,332
High /Low
725.0 / 382.0
Stock P/E
25.7
Book Value
₹141.0
Dividend Yield
0.29
ROCE
15.4
ROE
₹13.4
Face Value
1.0
PEG Ratio
2.25
EVEBITDA
₹13.7
Debt
1,097
CMP / FCF
114.0
Debt to equity
₹0.32
NP Ann
405
High price all time
725.0
Piotroski score
₹3.0
Graham Number
251.0
No. Eq. Shares
24.2
Net CF
₹89.5
Net profit
479
Price to book value
3.6
Interest Coverage
₹6.91
Low price all time
2.53
Industry PE
28.8
Reserves
₹3,403
Free Cash Flow
₹60.6

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
GRANULES INDIA LTD.11,376.954.8525.7
SANOFI INDIA LTD5,240.0035.6927.7
MARKSANS PHARMA LTD.6818.462.3127.9

Peer Comparison Chart


About GRANULES INDIA

Granules India Ltd., with Security Code 532482, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Stock recommendations by analysts for January 8: ONGC, Granules India and Bank of Baroda

(09 Jan 2025)
For Wednesday, analysts from a domestic brokerage assigned 'Buy/Sell' calls on ONGC, Granules India and Bank of Baroda shares.
Read more →

Granules India shares worth ₹191 crore change hands, an FII clean out trade likely: Exclusive

(20 Dec 2024)
Shares of Granules India Ltd. are fluctuating between gains and losses on Friday, December 20, after the company saw a large trade taking...
Read more →

Granules India Limited gets USFDA nod for ADHD treatment

(19 Dec 2024)
Granules India Limited on Wednesday announced that it has received approval from the U.S. Food & Drug Administration (USFDA) for its...
Read more →

Five Stocks To Buy Today: Zomato, Devyani, Granules, Supreme Industries And Godrej Properties

(18 Dec 2024)
Analysts have 'buy' calls for Zomato Ltd., Devyani International Ltd., Granules India Ltd., Supreme Industries Ltd. and Godrej Properties...
Read more →

Granules India subsidiary receives USFDA nod for ADHD treatment drug

(17 Dec 2024)
Granules India Share Price | The pharmaceutical company, in an exchange filing on Tuesday, said its wholly-owned foreign subsidiary,...
Read more →

Granules India gets USFDA nod for generic drug

(17 Dec 2024)
Granules Pharmaceuticals, Inc. secured USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets. The tablets treat ADHD in...
Read more →